EMA committee recommends new eczema injection from Leo Pharma
The EMA’s advisory panel, CHMP, has recommended Leo Pharma’s new prefilled pen used to deliver Adtralza (tralokinumab) against atopic eczema, writes Leo Pharma in a press release.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Leo Pharma appoints new general manager for UK and Ireland
For subscribers